Loading clinical trials...
Loading clinical trials...
MAGNOLIA: Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated With Non-Infectious Uveitis
Conditions
Interventions
4 mg CLS-TA Suprachoriodal Injection
Sham procedure
Locations
16
United States
Retinal Consultants of Arizona
Phoenix, Arizona, United States
Northern California Retina Vitreous Associates Medical Group, Inc.
Mountain View, California, United States
Retina Group of Florida
Fort Lauderdale, Florida, United States
Marietta Eye Clinic
Marietta, Georgia, United States
Valley Eye Physicians and Surgeons, PC
Ayer, Massachusetts, United States
Bergstrom Eye Research
Fargo, North Dakota, United States
Start Date
December 13, 2017
Primary Completion Date
May 22, 2018
Completion Date
May 22, 2018
Last Updated
June 2, 2021
NCT07218770
NCT05486468
NCT02706704
NCT06431373
NCT07262437
NCT07176130
Lead Sponsor
Clearside Biomedical, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions